Overrepresentation of genetic variation in the AnkyrinG interactome is related to a range of neurodevelopmental disorders
暂无分享,去创建一个
L. Vissers | A. Hoischen | B. D. de Vries | C. Gilissen | R. Kooy | A. van Dijck | P. D. de Vries | G. Vandeweyer | P. Vries | B. Vries | F. Kooy | M. Vorst | S. Jansen | I. M. van der Werf | A. Dijck | M. van de Vorst | Amber Gerstmans | I. V. D. Werf | P. D. Vries
[1] J. Aerts,et al. Predicting disease-causing variant combinations , 2019, Proceedings of the National Academy of Sciences.
[2] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[3] R. Pfundt,et al. Okur‐Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion , 2018, Clinical genetics.
[4] Y. Tsurusaki,et al. Refining the clinical phenotype of Okur–Chung neurodevelopmental syndrome , 2018, Human Genome Variation.
[5] Geert Vandeweyer,et al. pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data , 2017, BMC Bioinformatics.
[6] Heather Cody Hazlett,et al. Fragile X syndrome , 2017, Nature Reviews Disease Primers.
[7] Joan,et al. Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.
[8] L. Vissers,et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.
[9] G. Kirov,et al. Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy , 2016, BMC Medical Genetics.
[10] Sharyn A. Lincoln,et al. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features , 2016, Human Genetics.
[11] L. Vissers,et al. Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.
[12] Paul M. Jenkins,et al. Giant ankyrin-G: A critical innovation in vertebrate evolution of fast and integrated neuronal signaling , 2014, Proceedings of the National Academy of Sciences.
[13] Christopher S. Poultney,et al. Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.
[14] B. Schürmann,et al. Psychiatric Risk Factor ANK3/Ankyrin-G Nanodomains Regulate the Structure and Function of Glutamatergic Synapses , 2014, Neuron.
[15] Akash Kumar,et al. MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing , 2014, Bioinform..
[16] Bradley P. Coe,et al. The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[17] Stephan J Sanders,et al. A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.
[18] R. Kooy,et al. Fragile X syndrome neurobiology translates into rational therapy. , 2014, Drug discovery today.
[19] Stephen J. Guter,et al. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.
[20] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[21] J. Shendure,et al. A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.
[22] C. Baldwin,et al. The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity , 2013, Psychoneuroendocrinology.
[23] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[24] Y. Fukushima,et al. Clinical correlations of mutations affecting six components of the SWI/SNF complex: Detailed description of 21 patients and a review of the literature , 2013, American journal of medical genetics. Part A.
[25] L. Vissers,et al. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. , 2013, Human molecular genetics.
[26] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[27] Zhong Sheng Sun,et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility , 2012, Human mutation.
[28] Chen Zhang,et al. ANK3 as a risk gene for schizophrenia: New data in han Chinese and meta analysis , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[29] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[30] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[31] Allison G. Dempsey,et al. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders , 2012, Journal of Medical Genetics.
[32] Kenny Q. Ye,et al. De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.
[33] I. Scheffer,et al. KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy , 2012, Annals of neurology.
[34] Hans van Bokhoven,et al. Genetic and epigenetic networks in intellectual disabilities. , 2011, Annual review of genetics.
[35] J. Fak,et al. FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.
[36] J. Groothoff,et al. Prevalence of chronic health conditions in children with intellectual disability: a systematic literature review. , 2011, Intellectual and developmental disabilities.
[37] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[38] L. Isom,et al. Electrophysiology and beyond: Multiple roles of Na+ channel β subunits in development and disease , 2010, Neuroscience Letters.
[39] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[40] Elvira Bramon,et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. , 2010, Journal of psychiatric research.
[41] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[42] Jessica R. Wolff,et al. Microduplications of 16p11.2 are Associated with Schizophrenia , 2009, Nature Genetics.
[43] Jürgen-Markus Sobotzik,et al. AnkyrinG is required to maintain axo-dendritic polarity in vivo , 2009, Proceedings of the National Academy of Sciences.
[44] P. Stankiewicz,et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders , 2009, Journal of Medical Genetics.
[45] Christophe Leterrier,et al. Protein kinase CK2 contributes to the organization of sodium channels in axonal membranes by regulating their interactions with ankyrin G , 2008, The Journal of cell biology.
[46] S. Cichon,et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder , 2008, Molecular Psychiatry.
[47] Thomas W. Mühleisen,et al. Large recurrent microdeletions associated with schizophrenia , 2008, Nature.
[48] S. Gabriel,et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.
[49] Joshua M. Korn,et al. Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.
[50] I. Scheffer,et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. , 2006, Brain : a journal of neurology.
[51] Vann Bennett,et al. A Common Ankyrin-G-Based Mechanism Retains KCNQ and NaV Channels at Electrically Active Domains of the Axon , 2006, The Journal of Neuroscience.
[52] M. Hortsch,et al. Structural Requirements for Interaction of Sodium Channel β1 Subunits with Ankyrin* , 2002, The Journal of Biological Chemistry.
[53] M. Solimena,et al. βiv Spectrin, a New Spectrin Localized at Axon Initial Segments and Nodes of Ranvier in the Central and Peripheral Nervous System , 2000, The Journal of cell biology.
[54] Vann Bennett,et al. AnkyrinG Is Required for Clustering of Voltage-gated Na Channels at Axon Initial Segments and for Normal Action Potential Firing , 1998, The Journal of cell biology.
[55] Samuel F. Berkovic,et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B , 1998, Nature Genetics.
[56] W. Catterall,et al. Molecular Determinants of Na+ Channel Function in the Extracellular Domain of the β1 Subunit* , 1998, The Journal of Biological Chemistry.
[57] V. Bennett,et al. Molecular composition of the node of Ranvier: identification of ankyrin- binding cell adhesion molecules neurofascin (mucin+/third FNIII domain- ) and NrCAM at nodal axon segments , 1996, The Journal of cell biology.
[58] P. Vaglio,et al. Protein Kinase CK2 Mutants Defective in Substrate Recognition , 1996, The Journal of Biological Chemistry.
[59] Jack A. M. Leunissen,et al. Turning CFCs into salt. , 1996, Nucleic Acids Res..
[60] V. Bennett,et al. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.
[61] Claude-Alain H. Roten,et al. Theoretical and practical advances in genome halving , 2004 .